Related content

Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities

By Shoskes D.A.   Thomas M.   Pobgee R.   Fromkin B.   Copley J.B.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 841-842

Elsevier

Access to resources Recommend Favorite

Hypertriglyceridemia in renal transplant recipients treated with sirolimus

By Brattstrom C.   Wilczek H.E.   Tyden G.   Bottiger Y.   Sawe J.   Groth C.G.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 3950-3951

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment - Single-center experience

By Garcia C.E.   Ribeiro H.B.G.   Garcia R.L.   Copstein J.L.M.   Padilla J.M.   Santos T.E.   Amaral D.D.   Silva A.O.   D'Albuquerque L.A.C.  

Transplantation Proceedings, Vol. 35, Iss. 3, 2003-05 ,pp. : 1131-1132

Elsevier

Access to resources Recommend Favorite

Effect of calcineurin inhibitors on QT dispersion in renal transplant recipients

By Turkmen A.   Bunyak B.   Oflaz H.   Kucuk M.   Sahin S.   Bugra Z.   Umman B.   Sever M.S.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2996-2998

Elsevier

Access to resources Recommend Favorite

A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients

By Shapiro R.   Scantlebury V.P.   Jordan M.L.   Vivas C.A.   Jain A.   Hakala T.R.   McCauley J.   Johnston J.   Randhawa P.   Fedorek S.   Gray E.   Chesky A.   Dvorchik I.   Donaldson J.   Fung J.J.   Starzl T.E.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1651-1652

Elsevier

Access to resources Recommend Favorite